HRP20020367A2 - Agent for treating hepatitis c - Google Patents

Agent for treating hepatitis c Download PDF

Info

Publication number
HRP20020367A2
HRP20020367A2 HR20020367A HRP20020367A HRP20020367A2 HR P20020367 A2 HRP20020367 A2 HR P20020367A2 HR 20020367 A HR20020367 A HR 20020367A HR P20020367 A HRP20020367 A HR P20020367A HR P20020367 A2 HRP20020367 A2 HR P20020367A2
Authority
HR
Croatia
Prior art keywords
patients
ukrain
ifn
doses
chc
Prior art date
Application number
HR20020367A
Other languages
English (en)
Croatian (hr)
Inventor
Wassyl Nowicky
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Publication of HRP20020367A2 publication Critical patent/HRP20020367A2/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20020367A 2000-03-22 2001-03-20 Agent for treating hepatitis c HRP20020367A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c
PCT/AT2001/000076 WO2001070203A2 (de) 2000-03-22 2001-03-20 Mittel zur behandlung von hepatitis c, enthaltend ukrain

Publications (1)

Publication Number Publication Date
HRP20020367A2 true HRP20020367A2 (en) 2004-02-29

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020367A HRP20020367A2 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c

Country Status (17)

Country Link
JP (1) JP2003527414A (de)
KR (1) KR20020087045A (de)
CN (1) CN1416347A (de)
AT (1) AT408719B (de)
AU (1) AU2001239000A1 (de)
BG (1) BG107088A (de)
BR (1) BR0107211A (de)
CA (1) CA2389173A1 (de)
EA (1) EA200200584A1 (de)
HR (1) HRP20020367A2 (de)
IL (1) IL149314A0 (de)
IS (1) IS6360A (de)
MA (1) MA25509A1 (de)
MX (1) MXPA02004993A (de)
NO (1) NO20022253L (de)
PL (1) PL365000A1 (de)
WO (1) WO2001070203A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (de) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternäre Chelidonin- und Alkaloidderivate, Verfahren zu deren Herstellung und deren Verwendung in der Herstellung von Arzneimitteln
EP2083825A4 (de) * 2006-09-26 2009-11-04 Addiction Res Inst Inc Zusammensetzungen zur behandlung von hepatitis c und verfahren zur verwendung von zusammensetzungen zur behandlung von hepatitis c
CN106343303A (zh) * 2015-07-13 2017-01-25 张如安 灭杀乙肝病毒的饮料
CN106109538A (zh) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 治疗丙肝的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
PT93772A (pt) * 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer

Also Published As

Publication number Publication date
EA200200584A1 (ru) 2003-06-26
IL149314A0 (en) 2002-11-10
BR0107211A (pt) 2004-01-06
MA25509A1 (fr) 2002-07-01
BG107088A (en) 2003-05-30
WO2001070203A2 (de) 2001-09-27
JP2003527414A (ja) 2003-09-16
NO20022253D0 (no) 2002-05-10
AT408719B (de) 2002-02-25
CN1416347A (zh) 2003-05-07
NO20022253L (no) 2002-05-10
MXPA02004993A (es) 2003-10-14
PL365000A1 (en) 2004-12-27
IS6360A (is) 2002-04-24
KR20020087045A (ko) 2002-11-21
ATA4812000A (de) 2001-07-15
WO2001070203A3 (de) 2002-09-06
AU2001239000A1 (en) 2001-10-03
CA2389173A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
US6007805A (en) Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver
KR20010052622A (ko) 만성 씨형 간염을 치료하기 위한 폴리에틸렌글리콜-인터페론-알파 및 리바비린의 용도
TW200412960A (en) Potent inhibitor of HCV serine protease
CN103781355A (zh) 用拉喹莫德与干扰素-β的组合治疗多发性硬化症
KR20140054166A (ko) 라퀴니모드 및 글라티라머 아세테이트의 병용에 의한 다발성 경화증의 치료
WO2012017328A2 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
EP0270317A3 (de) Pharmaceutische Zuberatung zur Behandlung von Virus-Krankheiten
KR20060120037A (ko) Ｈｃｖ 감염 치료용 병용 요법
US5716941A (en) Use of methyl donor compounds to treat neurological dysfunction associated with immune defects
KR101174966B1 (ko) 철이 발병에 관여하는 간질환의 치료
US20220023287A1 (en) Treatment of hepatitis delta virus infection
KR20220119616A (ko) Tlr7 효현제를 이용하여 바이러스 감염을 치료하는 방법
US20220339233A1 (en) Compositions and methods for preventing recurrence of cancer
HRP20020367A2 (en) Agent for treating hepatitis c
WO1994001125A1 (en) Composition and method of treating hepatitis b
WO1994001125A9 (en) Composition and method of treating hepatitis b
Birk et al. IFN-α induces apoptosis of adipose tissue cells
KR20110101125A (ko) 염화암모늄의 치료적 용도
JPH08512311A (ja) 慢性疲労症候群治療用ヒ素医薬
JP2005505582A5 (de)
JPH04275231A (ja) 事故結果として多外傷を有する危険な患者に於て、臓器拒絶の予防及び（又は）処置に、スーパーオキシドジスムターゼを使用する方法
KR0126677B1 (ko) 항바이러스성 약제학적 조성물
CN110882240B (zh) 作为急性缺血性中风的治疗剂的多酚衍生物化合物6-cepn
RU2165254C2 (ru) Фармацевтическая композиция для лечения вирусных заболеваний
RU2234922C2 (ru) Антигриппозный комплексный препарат

Legal Events

Date Code Title Description
A1OB Publication of a patent application
OBST Application withdrawn